Page 2 - டெசெரா சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டெசெரா சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டெசெரா சிகிச்சை Today - Breaking & Trending Today

Alaska Permanent Fund sets $1.1 billion in commitments, investments

Alaska Permanent Fund sets $1.1 billion in commitments, investments
Print
Alaska Permanent Fund Corp., Juneau, made $1.1 billion in commitments and investments in the quarter ended Dec. 31, a report for the $73.8 billion sovereign wealth fund s board meeting this week shows.
Within real estate, APFC committed $300 million to Clarion Gables Multifamily Trust, an open-end real estate fund managed by
Clarion Partners, and also committed $250 million to an associated co-investment vehicle with Clarion.
As of Dec. 31, the actual allocation to real estate was 6.6%; the target is 7%.
Within its private equity and special opportunities asset class, the sovereign wealth fund committed $75 million each to Centerbridge Capital Partners IV, a buyout fund managed by ....

United States , Alaska Permanent Fund Corp , Bain Capital Fund , Tessera Therapeutics Inc , Berkshire Fund , Technology Crossover Ventures , Codiak Biosciences Inc , Clarion Gables Multifamily , Capstone Logistics , Clarion Gables Multifamily Trust , Clarion Partners , Centerbridge Capital Partners , Centerbridge Partners , Berkshire Partners , North American , Tessera Therapeutics , Codiak Biosciences , Summit Partners , Kicking Horse , Whitehorse Liquidity Partners , ஒன்றுபட்டது மாநிலங்களில் , அலாஸ்கா நிரந்தர நிதி கார்ப் , பைன் மூலதனம் நிதி , டெசெரா சிகிச்சை இன்க் , பெர்க்ஷயர் நிதி , தொழில்நுட்பம் குறுக்குவழி முயற்சிகள் ,

Judicial Notice: February 6, 2021

March 8, 2021 at 3:17 PM
Shares6
A courtroom in the Pioneer Courthouse in Portland, Oregon (photo by David Lat).
Ed. note: This column originally appeared on Original Jurisdiction, the new Substack publication from David Lat. Judicial Notice is a weekly review of notable legal news that appears each Saturday. You can register to receive Judicial Notice and other updates from Original Jurisdiction through this signup page.
As Original Jurisdiction hits the two-month mark, I’m happy to report that I’m just a few readers shy of 2,000 subscribers. Thanks to all of you for subscribing and helping to spread the word.
Now, on to the news. ....

New York , United States , France General , District Of Columbia , City Of , United Kingdom , San Francisco , West Virginia , Stone Point , Orange County , University Of Houston , Raffi Melkonian , Emmanuel Gaillard , Amy Paulin , Scott Kamholz , Lehotsky Keller , Dickinson Wright , Boies Schiller , Waller Lansden Dortch Davis , David Schoen , Adalberto Jordan , Barry Berke , Brad Hoylman , Kasowitz Benson , Maria Bartiromo , Maier Neustadt ,

List of Softbank's 11 biggest healthcare investments

What it does:10x Genomics makes software for researchers to perform single cell and whole genome sequencing. Its software can be used for immunotherapy and cell therapy research in cancer patients or patients with rare genetic disorders. The Silicon Valley-based company was founded by Serge Saxonov, formerly the founding director of research at consumer genetics company 23andMe.
Deal details: SoftBank participated in the company s $125 million Series D funding round in 2018 that valued the company at $1.25 billion. It went public in September 2019 and was valued above $3.6 billion in its debut. SoftBank is no longer invested in 10x Genomics.
Other investors: Venrock, Fidelity International, Foresight Capital Management, and Paladin Capital Group ....

Jackson Square , United States , United Kingdom , Perth And Kinross , San Francisco , Nick Watney , Kevin Durant , Jack Dorsey , Serge Saxonov , Baillie Gifford , Patrick Mahomes , Jeffrey Huber , Eli Manning , Silicon Valley Bank , Qatar Investment Authority , Rock Health , Alaska Permanent Fund , Temasek Holdings , Shanda Group , Tencent Holdings , Atlas Venture , Ge Healthcare , Founders Fund , Schiehallion Fund , Paladin Capital Group , Pilot House Ventures Group ,

Tessera Raises $230M to Develop 'Gene Writing' into Novel Genetic Therapy

At the J.P Morgan Healthcare Conference, Tessera announced its procurement of a second round of funding worth $230 million. ....

United States , Noubar Afeyan , Softbank Vision Fund , Qatar Investment Authority , Alaska Permanent Fund Corporation , Tessera Therapeutics , Flagship Labs , Altitude Life Science Ventures , Gene Writing , Flagship Pioneering , Gene Therapy , Series B , ஒன்றுபட்டது மாநிலங்களில் , சாப்ட் பேங்க் பார்வை நிதி , கத்தார் முதலீடு அதிகாரம் , அலாஸ்கா நிரந்தர நிதி நிறுவனம் , டெசெரா சிகிச்சை , முதன்மையானது ஆய்வகங்கள் , உயரம் வாழ்க்கை அறிவியல் முயற்சிகள் , கீந் எழுதுதல் , கீந் சிகிச்சை ,

Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance 'Gene Writing' – A New Category in Genetic Medicine

News Category Global Banking & Finance Reviews
Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’ – A New Category in Genetic Medicine
Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’ – A New Category in Genetic Medicine
Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised over $230M in Series B financing. The round was co-led by Alaska Permanent Fund Corporation, Altitude Life Science Ventures, and SoftBank Vision Fund 2
i, with participation from Qatar Investment Authority (QIA) and others.
Tessera, unveiled in July 2020 after multiple years of in-house innovation within Flagship Labs, is pioneering Gene Writinga new technology that has the ability to write therapeutic instructions into the genome to treat diseases at their source. By changing any base pair to another, making small insertions or ....

United States , Noubar Afeyan , Softbank Vision Fund , Qatar Investment Authority , Alaska Permanent Fund Corporation , Axcella Health , Tessera Therapeutics , Flagship Pioneering , Altitude Life Science Ventures , Flagship Labs , Gene Writinga , Gene Writing , Tesseras Gene Writing , Denali Therapeutics , Evelo Biosciences , Foghorn Therapeutics , Kaleido Biosciences , Rubius Therapeutics , Sana Biotechnology , Seres Therapeutics , Sigilon Therapeutics , ஒன்றுபட்டது மாநிலங்களில் , சாப்ட் பேங்க் பார்வை நிதி , கத்தார் முதலீடு அதிகாரம் , அலாஸ்கா நிரந்தர நிதி நிறுவனம் , டெசெரா சிகிச்சை ,